TULIP GENESIS
-
Regulatory
MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI platform technology
August 02, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More »